Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Shen

Showing results (441-450 of 465) with videos related to

Pageof 47
Sort By:
Mutagenesis|August 20, 2011
Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needsStuart Creton, Marilyn J Aardema, Paul L Carmichael, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)M G Fury, E J Sherman, S S Rao, et al.
Journal of Medicinal Chemistry|September 1, 2000
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitorsA Wissner, D M Berger, D H Boschelli, et al.
American Journal of Cancer Research|July 15, 2024
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphomaTom van Meerten, John Kuruvilla, Kevin W Song, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Effects of testosterone replacement in human immunodeficiency virus-infected women with weight lossH H Choi, P B Gray, T W Storer, et al.
Molecular Cell|July 14, 1998
XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damagesN Liu, J E Lamerdin, R S Tebbs, et al.
Blood Cancer Discovery|November 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, et al.
Nature Communications|June 18, 2024
Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutininRuipeng Lei, Weiwen Liang, Wenhao O Ouyang, et al.
Cancer Research|October 19, 2005
Multiple roles for the receptor tyrosine kinase axl in tumor formationSacha J Holland, Mark J Powell, Christian Franci, et al.
Neurogastroenterology and Motility|July 22, 2014
Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesisC E Bernard, S J Gibbons, I S Mann, et al.
Pageof 47

Showing results (441-450 of 465) with videos related to

Sort By:
Pageof 47
Mutagenesis|August 20, 2011
Cell transformation assays for prediction of carcinogenic potential: state of the science and future research needsStuart Creton, Marilyn J Aardema, Paul L Carmichael, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 6, 2014
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)M G Fury, E J Sherman, S S Rao, et al.
Journal of Medicinal Chemistry|September 1, 2000
4-Anilino-6,7-dialkoxyquinoline-3-carbonitrile inhibitors of epidermal growth factor receptor kinase and their bioisosteric relationship to the 4-anilino-6,7-dialkoxyquinazoline inhibitorsA Wissner, D M Berger, D H Boschelli, et al.
American Journal of Cancer Research|July 15, 2024
Impact of debulking therapy on the clinical outcomes of axicabtagene ciloleucel in the treatment of relapsed or refractory large B-cell lymphomaTom van Meerten, John Kuruvilla, Kevin W Song, et al.
The Journal of Clinical Endocrinology and Metabolism|December 23, 2004
Effects of testosterone replacement in human immunodeficiency virus-infected women with weight lossH H Choi, P B Gray, T W Storer, et al.
Molecular Cell|July 14, 1998
XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damagesN Liu, J E Lamerdin, R S Tebbs, et al.
Blood Cancer Discovery|November 20, 2023
Product Attributes of CAR T-cell Therapy Differentially Associate with Efficacy and Toxicity in Second-line Large B-cell Lymphoma (ZUMA-7)Simone Filosto, Saran Vardhanabhuti, Miguel A Canales, et al.
Nature Communications|June 18, 2024
Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutininRuipeng Lei, Weiwen Liang, Wenhao O Ouyang, et al.
Cancer Research|October 19, 2005
Multiple roles for the receptor tyrosine kinase axl in tumor formationSacha J Holland, Mark J Powell, Christian Franci, et al.
Neurogastroenterology and Motility|July 22, 2014
Association of low numbers of CD206-positive cells with loss of ICC in the gastric body of patients with diabetic gastroparesisC E Bernard, S J Gibbons, I S Mann, et al.
Pageof 47